Amedeo Smart

Free Medical Literature Service

 

Amedeo

Nuclear Medicine
  Free Subscription

Articles published in
J Nucl Cardiol
    October 2025
  1. SOBY JH, Mortensen J, Rasmussen LD, Tolbod LP, et al
    Systematic Differences in Myocardial Blood Flow and Flow Reserve Quantification Using Rubidium-82 and [(15)O]H(2)O PET: Implications for Prognostic Cut-Offs.
    J Nucl Cardiol. 2025 Oct 17:102533. doi: 10.1016/j.nuclcard.2025.102533.
    >> Share

  2. HYUN MC, Brown A, Calnon DA
    SCANNER ROOM CRISIS: Bridging THE WORKFORCE SHORTAGE GAP of Nuclear Medicine Technologists.
    J Nucl Cardiol. 2025 Oct 17:102527. doi: 10.1016/j.nuclcard.2025.102527.
    >> Share

  3. BARRETT O, Shanbhag A, Zaid R, Miller RJH, et al
    Incremental diagnostic value of AI-derived coronary artery calcium in (18)F-flurpiridaz PET Myocardial Perfusion Imaging.
    J Nucl Cardiol. 2025 Oct 14:102532. doi: 10.1016/j.nuclcard.2025.102532.
    >> Share

  4. LIMA RSL, de Lorenzo A, Palazzo IC, Mesquita CT, et al
    How to Perform Quantification of Myocardial Blood Flow using SPECT MPI How to use Nuclear Cardiology.
    J Nucl Cardiol. 2025 Oct 14:102534. doi: 10.1016/j.nuclcard.2025.102534.
    >> Share

  5. MOULTON E, Gagliano L, Kaviani S, Klein R, et al
    Artificial Intelligence-enabled parametric mapping of myocardial blood flow with (82)Rb PET compared to (18)F-flurpiridaz perfusion imaging: A paired pilot study of image quality.
    J Nucl Cardiol. 2025 Oct 13:102531. doi: 10.1016/j.nuclcard.2025.102531.
    >> Share

  6. WANG Y
    Beyond Rest-Stress: Expanding Rapid (18)F-Flurpiridaz PET to Post-Stress Viability and Quantifying Coronary Flow Reserve.
    J Nucl Cardiol. 2025 Oct 10:102529. doi: 10.1016/j.nuclcard.2025.102529.
    >> Share

  7. SAYED A, Al Rifai M, El Yaman A, Alwan M, et al
    Differential Association of Heart Rate Response to Regadenoson with Death and Heart Failure Hospitalizations According to Ejection Fraction in Patients Undergoing PET MPI.
    J Nucl Cardiol. 2025 Oct 8:102508. doi: 10.1016/j.nuclcard.2025.102508.
    >> Share

  8. ACAMPA W, Cantoni V
    Positron emission tomography computed tomography versus cadmium zinc telluride single-photon emission computer tomography in myocardial flow quantification: Bridging the gap or replacing a standard?
    J Nucl Cardiol. 2025;52:102443.
    >> Share

  9. DI CARLI MF
    What if SPECT could do it all?
    J Nucl Cardiol. 2025;52:102510.
    >> Share

  10. CSECS I, Sharma A, Khungar V, Sinusas AJ, et al
    Blunted hemodynamic response to pharmacological stress is predictive of mortality in liver transplant candidates.
    J Nucl Cardiol. 2025;52:102454.
    >> Share

    September 2025
  11. PASCALE R, Fernandez-Hidalgo N, Tazza B, Bartoletti M, et al
    How to manage patients receiving long-term suppressive antibiotic treatment for infective endocarditis: the role of [18F]-FDG-PET/CT imaging - An international multidisciplinary survey.
    J Nucl Cardiol. 2025 Sep 27:102505. doi: 10.1016/j.nuclcard.2025.102505.
    >> Share

  12. KHAN MS, Perumalla HS, Modi K, Asif T, et al
    National Trends in Radiopharmaceutical Use for the Diagnosis of Cardiac Amyloidosis from 2019-2024.
    J Nucl Cardiol. 2025 Sep 26:102502. doi: 10.1016/j.nuclcard.2025.102502.
    >> Share

  13. DALEBOUT EM, Hirsch A, Mulders TA, Segbers M, et al
    Optimization of timing window and gating method for (18)F-FDG PET/CT in patients with suspected prosthetic valve endocarditis: A prospective pilot study.
    J Nucl Cardiol. 2025 Sep 20:102501. doi: 10.1016/j.nuclcard.2025.102501.
    >> Share

  14. PACKARD RRS, Maddahi J, Pelletier-Galarneau M, Al-Mallah MH, et al
    SNMMI/EANM/ASNC/ACNM procedure standard/practice guideline for (18)F-Flurpiridaz PET myocardial perfusion imaging and blood flow quantitation.
    J Nucl Cardiol. 2025 Sep 18:102473. doi: 10.1016/j.nuclcard.2025.102473.
    >> Share

  15. MILLER RJH, Barrett O, Shanbhag A, Rozanski A, et al
    Integrating Perfusion with AI-derived Coronary Calcium on CT attenuation scans to improve selection of low-risk studies for stress-only SPECT MPI.
    J Nucl Cardiol. 2025 Sep 10:102482. doi: 10.1016/j.nuclcard.2025.102482.
    >> Share

  16. LIMA BB, Kronenberg MW, Carr CM, Duran J, et al
    How to Prepare Patients for (18)F-FDG PET Myocardial Viability Assessment.
    J Nucl Cardiol. 2025 Sep 2:102480. doi: 10.1016/j.nuclcard.2025.102480.
    >> Share

  17. AJIMA T, Aikawa T, Saitou T, Matsue Y, et al
    Prognostic value of (99m)Tc-pyrophosphate uptake in patients with suspected transthyretin cardiac amyloidosis.
    J Nucl Cardiol. 2025;51:102452.
    >> Share

  18. BENZ DC, Flammer AJ, Schwotzer R, Buechel RR, et al
    How to perform and interpret cardiac amyloidosis radionuclide imaging (CARI).
    J Nucl Cardiol. 2025;51:102448.
    >> Share

    August 2025
  19. RAMIREZ G, Lemley M, Shanbhag A, Kwiecinski J, et al
    The REgistry of Flow and Perfusion Imaging for Artificial INtelligEnce with PET(REFINE PET): Rationale and Design.
    J Nucl Cardiol. 2025 Aug 5:102449. doi: 10.1016/j.nuclcard.2025.102449.
    >> Share

  20. SCHERPING SC 3RD, Ahmad SM, Katz SM, Hosadurg N, et al
    The prevalence and prognostic impact of additive abnormal stress exercise markers in patients with normal stress myocardial perfusion imaging.
    J Nucl Cardiol. 2025;50:102267.
    >> Share

    July 2025
  21. RENAUD JM, Moody JB, Vanderver MD, Poitrasson-Riviere A, et al
    Improved diagnostic performance of (18)F-flurpiridaz PET myocardial blood flow quantification with automated dynamic motion correction.
    J Nucl Cardiol. 2025 Jul 25:102450. doi: 10.1016/j.nuclcard.2025.102450.
    >> Share

  22. CLAUDIO FD, Siddiqui S, Gil FR, Morley-Smith A, et al
    Unmasking Deep Sternal Wound Infection After Cardiac Transplant: The Diagnostic and Monitoring Value of (18)F-FDG PET/CT.
    J Nucl Cardiol. 2025 Jul 25:102447. doi: 10.1016/j.nuclcard.2025.102447.
    >> Share

  23. GU Y, Sun R, Ren W, Xi X, et al
    Preclinical and first-in-human studies of a novel tracer for SPECT myocardial blood flow quantification.
    J Nucl Cardiol. 2025 Jul 15:102441. doi: 10.1016/j.nuclcard.2025.102441.
    >> Share

  24. WANG S, Luan Q, Cheng Z, Li Y, et al
    (18)F-FAP-2286 and (18)F-FDG PET/CT imaging in a rare case of asymptomatic indolent cardiac hemangioma in the right ventricle.
    J Nucl Cardiol. 2025 Jul 15:102442. doi: 10.1016/j.nuclcard.2025.102442.
    >> Share

  25. HIJAZI W, Feng Y, Southern DA, Chew D, et al
    Corrigendum to "Association of medical therapies with survival according to SPECT MPI findings" [J Nucl Cardiol 3 May 2025; 102229].
    J Nucl Cardiol. 2025 Jul 15:102440. doi: 10.1016/j.nuclcard.2025.102440.
    >> Share

  26. ALI SM, Sathian B, Iqbal J, Muhammad K, et al
    Caution in Interpreting PET-Negative Fibrosis: Commentary on the Diagnostic Scope of 13N-Ammonia PET in Non-Ischemic Cardiomyopathies.
    J Nucl Cardiol. 2025 Jul 8:102300. doi: 10.1016/j.nuclcard.2025.102300.
    >> Share

  27. BROWN JM, Huck DM
    Total-Body PET: Investigating Mechanisms in Cardiovascular-Kidney-Metabolic Syndrome.
    J Nucl Cardiol. 2025 Jul 5:102299. doi: 10.1016/j.nuclcard.2025.102299.
    >> Share

  28. WRIGHT CX, Spatz ES
    Leveraging stress testing as a risk modifier: Optimization of medical therapy after SPECT MPI.
    J Nucl Cardiol. 2025;49:102282.
    >> Share

  29. AL RIFAI M, Ahmed AI, Nayfeh M, Nabi F, et al
    The prognostic significance of rate pressure product corrected myocardial flow reserve.
    J Nucl Cardiol. 2025;49:102222.
    >> Share

    June 2025
  30. SPILLER WH, SathyaMurthi B, Arumugam P
    Unexpected insight: Rubidium-82 PET/CT myocardial perfusion imaging uncovers malignant pleural mesothelioma.
    J Nucl Cardiol. 2025 Jun 16:102264. doi: 10.1016/j.nuclcard.2025.102264.
    >> Share

  31. YAHIRO DS, Silva LFLD, Junior GL, Al-Mallah MH, et al
    Comparison of PET-CT and CZT-SPECT on Myocardial Blood Flow and Flow Reserve measurement: a systematic review and meta-analysis.
    J Nucl Cardiol. 2025 Jun 15:102279. doi: 10.1016/j.nuclcard.2025.102279.
    >> Share

  32. RENAUD JM, Moody JB, Vanderver MD, Poitrasson-Riviere A, et al
    Diagnostic performance of (18)F-flurpiridaz PET myocardial perfusion imaging with total perfusion deficit quantification.
    J Nucl Cardiol. 2025 Jun 15:102266. doi: 10.1016/j.nuclcard.2025.102266.
    >> Share

  33. MALIK AP, Parvez Malik UF, Iqbal J, Sathian B, et al
    Comment on "Validation of [99mTc]Tc-HMDP SPECT/CT Myocardial Uptake Quantification for the Detection of ATTR Cardiomyopathy".
    J Nucl Cardiol. 2025 Jun 13:102272. doi: 10.1016/j.nuclcard.2025.102272.
    >> Share

  34. LEGALLOIS D, Turcan L, Agostini D, Manrique A, et al
    Test-retest Reproducibility of Myocardial (99m)Tc-HMDP Uptake Quantification by SPECT-CT in Suspected Transthyretin Cardiac Amyloidosis.
    J Nucl Cardiol. 2025 Jun 13:102273. doi: 10.1016/j.nuclcard.2025.102273.
    >> Share

  35. ROMERO PABON AJ, Clerc OF, Cuddy SAM, Vijayakumar S, et al
    Prognostic Value of (99m)technetium-PYP SPECT Visual Grade in Patients with Transthyretin Cardiac Amyloidosis on Stabilization Therapy.
    J Nucl Cardiol. 2025 Jun 13:102275. doi: 10.1016/j.nuclcard.2025.102275.
    >> Share

  36. CROWLEY LE, Jenkins E, Ranasinghe A, Naneishvili T, et al
    Serial (18)F-Fluorodeoxyglucose Positron Emission Tomography to Assess the Efficacy of Infliximab in Steroid Refractory Cardiac Sarcoidosis.
    J Nucl Cardiol. 2025 Jun 9:102265. doi: 10.1016/j.nuclcard.2025.102265.
    >> Share

  37. KADRMAS DJ, Kemp BJ, Sitek A, Chareonthaitawee P, et al
    Technical Evaluation of Immediate Back-to-Back Rest-Stress PET Scanning with (18)F-Flurpiridaz.
    J Nucl Cardiol. 2025 Jun 9:102268. doi: 10.1016/j.nuclcard.2025.102268.
    >> Share

  38. FUJITO H, Lemley M, Builoff V, Zhang W, et al
    (82)Rb PET Myocardial Blood Flow Quantification: Influence of Arterial Input Curve Quality on Diagnostic Accuracy.
    J Nucl Cardiol. 2025 Jun 7:102270. doi: 10.1016/j.nuclcard.2025.102270.
    >> Share

  39. MANABE O
    AI-driven quantification in (18)F-fluorodeoxyglucose positron emission tomography imaging for cardiac sarcoidosis: A step toward objectivity and reproducibility.
    J Nucl Cardiol. 2025;48:102224.
    >> Share

  40. AL RIFAI M, Alwan M, Ahmed AI, Nabi F, et al
    The impact of obesity on myocardial flow reserve and its prognostic utility.
    J Nucl Cardiol. 2025;48:102193.
    >> Share

    May 2025
  41. ALWAN M, Sayed A, Ahmed AI, Shaikh A, et al
    The Impact of Attenuation Correction and Prone Positioning on Stress-Only Imaging in Cardiac SPECT: An Observational Study.
    J Nucl Cardiol. 2025 May 20:102249. doi: 10.1016/j.nuclcard.2025.102249.
    >> Share

  42. DALEBOUT EM, Swart LE, Kluin J, Weustink AC, et al
    (18)F-FDG PET-CT in patients with prosthetic heart valves: variations in imaging findings: A review of the literature.
    J Nucl Cardiol. 2025 May 17:102247. doi: 10.1016/j.nuclcard.2025.102247.
    >> Share

  43. ALWAN M, El Yaman A, Sayed A, Shaikh A, et al
    Cardiac Positron emission tomography/ computed tomography (PET/CT) in current cardiology guidelines.
    J Nucl Cardiol. 2025 May 8:102231. doi: 10.1016/j.nuclcard.2025.102231.
    >> Share

  44. HIJAZI W, Feng Y, Southern DA, Chew D, et al
    Association of Medical Therapies with Survival According to SPECT MPI Findings.
    J Nucl Cardiol. 2025 May 3:102229. doi: 10.1016/j.nuclcard.2025.102229.
    >> Share

  45. OSBORNE MT, Al-Mallah MH
    Probing the shadows of myocardial scar: Can PET MPI see what MRI sees?
    J Nucl Cardiol. 2025;47:102221.
    >> Share

  46. LEE SN, Malhotra P, Miller RJH, Gransar H, et al
    Independent prognostic significance of myocardial flow reserve over coronary artery calcium, myocardial perfusion, and clinical variables in patients without known coronary artery disease, according to diabetes status.
    J Nucl Cardiol. 2025;47:102165.
    >> Share

  47. HSU TJ, Tseng CT, Kuo L, Yang CY, et al
    AHL amyloidosis mimicking transthyretin amyloidosis on cardiac Tc-99 m pyrophosphate scan: A diagnostic challenge.
    J Nucl Cardiol. 2025;47:102147.
    >> Share

    April 2025
  48. SPRAUEL T, Imbert L, Doyeux K, Perrin M, et al
    Assessment of Sestamibi CZT-SPECT Reconstructed Using Deep-Learning-Based Virtual Attenuation Correction Maps According to Coronary Artery Territory and With Comparison to Rubidium-PET.
    J Nucl Cardiol. 2025 Apr 19:102226. doi: 10.1016/j.nuclcard.2025.102226.
    >> Share

  49. SHINN K, Henderson CS, Schenone AL, Goonewardena SN, et al
    Can ChatGPT answer patients' questions about nuclear stress tests and (18)F-Flurodeoxyglucose PET for myocardial inflammation?
    J Nucl Cardiol. 2025 Apr 5:102174. doi: 10.1016/j.nuclcard.2025.102174.
    >> Share

  50. DIVAKARAN S, Harms HJ, Robertson M, Merugumala SK, et al
    Post-walking exercise skeletal muscle perfusion and energetics in patients with symptomatic lower extremity peripheral artery disease.
    J Nucl Cardiol. 2025;46:102143.
    >> Share

  51. CALLEGARI S, Mena-Hurtado C, Smolderen KG, Thorn S, et al
    New horizons in nuclear cardiology: Imaging of peripheral arterial disease.
    J Nucl Cardiol. 2025;46:102079.
    >> Share

    March 2025
  52. SUOMALAINEN O, Ahokas T, Hippelainen E, Helio T, et al
    Validation of [(99m)Tc]Tc-HMDP SPECT/CT Myocardium-to-blood Ratio for the Detection of ATTR Cardiomyopathy.
    J Nucl Cardiol. 2025 Mar 28:102199. doi: 10.1016/j.nuclcard.2025.102199.
    >> Share

  53. NAZIF K, Abuzaid AS, Horgan S, Patel KK, et al
    Role of Rubidium-82 positron emission tomography in a multimodality approach to diagnosing Coronary Microvascular Dysfunction in Apical Hypertrophic Cardiomyopathy.
    J Nucl Cardiol. 2025 Mar 25:102197. doi: 10.1016/j.nuclcard.2025.102197.
    >> Share

  54. NIKOLAKOPOULOS I, Csecs I, Liu YH, Sinusas AJ, et al
    Temporal changes in PET myocardial flow reserve: implications for cardiovascular outcomes.
    J Nucl Cardiol. 2025 Mar 24:102194. doi: 10.1016/j.nuclcard.2025.102194.
    >> Share

  55. MILLER RJ, Shanbhag A, Marcinkiewicz AM, Struble H, et al
    AI-enabled CT-guided end-to-end quantification of total cardiac activity in 18FDG cardiac PET/CT for detection of cardiac sarcoidosis.
    J Nucl Cardiol. 2025 Mar 22:102195. doi: 10.1016/j.nuclcard.2025.102195.
    >> Share

  56. HEINIGER PS, Igual GD, Galafton A, Albertini T, et al
    Impact of transmurality and location on the diagnostic performance of 13N-ammonia PET in the detection of myocardial fibrosis - A hybrid PET/MR study.
    J Nucl Cardiol. 2025 Mar 1:102172. doi: 10.1016/j.nuclcard.2025.102172.
    >> Share

  57. PERRIN M, Claudin M, Djaballah K, Boursier C, et al
    Diagnostic accuracy of low-dose myocardial perfusion imaging in a real-world setting.
    J Nucl Cardiol. 2025;45:102140.
    >> Share

  58. BUILOFF V, Shanbhag A, Miller RJ, Dey D, et al
    Evaluating AI proficiency in nuclear cardiology: Large language models take on the board preparation exam.
    J Nucl Cardiol. 2025;45:102089.
    >> Share

  59. BOURQUE JM, Beanlands RSB, Berman DS, Chareonthaitawee P, et al
    F-18 flurpiridaz positron emission tomography myocardial perfusion imaging combined with treadmill exercise testing.
    J Nucl Cardiol. 2025;45S:102170.
    >> Share

  60. MADDAHI J
    (18)F flurpiridaz PET MPI: Imaging characteristics and clinical trials.
    J Nucl Cardiol. 2025;45S:102175.
    >> Share

  61. PATEL KK, Horgan S, Heller GV, Bateman TM, et al
    F-18-Flurpiridaz positron emission tomography myocardial perfusion imaging clinical results in specific patient populations.
    J Nucl Cardiol. 2025;45S:102166.
    >> Share

  62. DI CARLI MF
    The rise of quantitative positron emission tomography: Redefining the evaluation of coronary artery disease.
    J Nucl Cardiol. 2025;45S:102179.
    >> Share

  63. AL-MALLAH MH, Al Badarin F, Bengel F, Grossman GB, et al
    Potential worldwide impact of F-18 Flurpiridaz positron emission tomography myocardial perfusion imaging.
    J Nucl Cardiol. 2025;45S:102167.
    >> Share

  64. PACKARD RRS, deKemp RA, Knuuti J, Moody JB, et al
    Quantitative approaches to (18)F-flurpiridaz positron emission tomography image analysis.
    J Nucl Cardiol. 2025;45S:102180.
    >> Share

    February 2025
  65. OMOTE K, Oi M, Aikawa T
    Serial assessment of DWIBS-MRI and (18)F-fluorodexyglcose PET/CT after corticosteroid therapy in Takayasu arteritis.
    J Nucl Cardiol. 2025 Feb 28:102171. doi: 10.1016/j.nuclcard.2025.102171.
    >> Share

  66. XIE H, Alashi A, Thorn SL, Chen X, et al
    Increasing angular sampling for dedicated cardiac SPECT scanner: Implementation with Deep Learning and Validation with human data.
    J Nucl Cardiol. 2025 Feb 20:102168. doi: 10.1016/j.nuclcard.2025.102168.
    >> Share

  67. MOU T, Meng J, Lin C, Xie X, et al
    XTR003, a Fatty-acid Metabolism PET Tracer: A Phase I Study to Evaluate the Safety, Biodistribution, Radiation Dosimetry and Pharmacokinetics in Healthy Volunteers.
    J Nucl Cardiol. 2025 Feb 7:102144. doi: 10.1016/j.nuclcard.2025.102144.
    >> Share

  68. TUBBEN A, Prakken NHJ, Ivashchenko OV, Tingen HSA, et al
    Feasibility of the Absolute Quantification and Left Ventricular Segmentation of Cardiac Sympathetic Innervation in Wild-type Transthyretin Amyloidosis Cardiomyopathy with [(123)I]-MIBG SPECT/CT: the I-NERVE study.
    J Nucl Cardiol. 2025 Feb 3:102146. doi: 10.1016/j.nuclcard.2025.102146.
    >> Share

  69. NYE JA, Tipnis SV
    Addressing motion in the estimation of myocardial blood flow with [F-18] flurpiridaz positron emission tomography.
    J Nucl Cardiol. 2025;44:102123.
    >> Share

  70. RISCHPLER C
    'TIDing' over the uncertainty: Prognostic value of Transient Ischemic Dilation in Rubidium-82 PET myocardial perfusion imaging.
    J Nucl Cardiol. 2025;44:102142.
    >> Share

  71. MENGESHA B, Small G, Paterson DI, Chow B, et al
    Transient ischemic dilatation in cardiac amyloidosis.
    J Nucl Cardiol. 2025;44:102042.
    >> Share

    January 2025
  72. WIEFELS C, Boczar K, Birnie D, Beanlands R, et al
    Quantification of metabolic activity in the evaluation of cardiac sarcoidosis.
    J Nucl Cardiol. 2025;43:102088.
    >> Share

  73. TORRES A, Yerkan A, Abbasi A, Doukky R, et al
    The prognostic utility of heart rate and blood pressure response to regadenoson stress.
    J Nucl Cardiol. 2025;43:102050.
    >> Share

  74. VEERWAL H, Preet K, Sood A, Singh H, et al
    Incidentally detected diaphragmatic eventration as para-cardiac thoracic activity on myocardial perfusion imaging.
    J Nucl Cardiol. 2025;43:101817.
    >> Share

    December 2024
  75. LOGANATH K, Craig N, Barton A, Joshi S, et al
    Cardiovascular PET imaging of fibroblast activation A review of the current literature.
    J Nucl Cardiol. 2024 Dec 11:102106. doi: 10.1016/j.nuclcard.2024.102106.
    >> Share

  76. WU J, Young BD, Liu H, Sadeghi MM, et al
    Parametric FDG PET K(i) images using dual-time-point imaging data for cardiac sarcoidosis: a proof of concept study.
    J Nucl Cardiol. 2024 Dec 7:102121. doi: 10.1016/j.nuclcard.2024.102121.
    >> Share

  77. CLERC OF, Saraste A
    The heart has a memory: Let's not forget to interrogate it with (18)F-FDG PET.
    J Nucl Cardiol. 2024;42:102087.
    >> Share

  78. ZHANG F, Yang X, Chen Y, Shao X, et al
    Incremental prognostic value of (18)F-fluorodeoxyglucose myocardial ischemic memory imaging for major adverse cardiovascular events in patients with suspected unstable angina.
    J Nucl Cardiol. 2024;42:102051.
    >> Share

  79. LUCINIAN YA, Martineau P, Abikhzer G, Harel F, et al
    Novel tracers to assess myocardial inflammation with radionuclide imaging.
    J Nucl Cardiol. 2024;42:102012.
    >> Share

    November 2024
  80. MOTWANI M
    I can see clearly now the blur has gone - deep learning efficiencies in SPECT myocardial perfusion imaging.
    J Nucl Cardiol. 2024 Nov 30:102091. doi: 10.1016/j.nuclcard.2024.102091.
    >> Share

  81. ROJULPOTE C, Bhattaru A, Patil S, Adams SL, et al
    Assessing the Effect of Repeat PET Imaging on Treatment Response and Cardiovascular Outcomes among a Homogenously Treated Cohort of Patients with Suspected Cardiac Sarcoidosis.
    J Nucl Cardiol. 2024 Nov 21:102082. doi: 10.1016/j.nuclcard.2024.102082.
    >> Share

  82. KHOO CY, Maning J, Weinberg R, Avery R, et al
    Correlation between Technetium-99m pyrophosphate myocardial uptake and extracellular volume on cardiac magnetic resonance imaging in patients with transthyretin cardiac amyloidosis.
    J Nucl Cardiol. 2024 Nov 19:102083. doi: 10.1016/j.nuclcard.2024.102083.
    >> Share

  83. PATEL KK, Lim P, Peri-Okonny PA, Singh A, et al
    Prognostic value of Transient Ischemic Dilation on Rubidium-82 Positron Emission Tomography Myocardial Perfusion Imaging.
    J Nucl Cardiol. 2024 Nov 16:102084. doi: 10.1016/j.nuclcard.2024.102084.
    >> Share

  84. TOUMA R, Njeim M, Jebara V, Abidov A, et al
    Cardiac PET and CMR in Diagnosis of Epi-pericardial Fat Necrosis Associated with Severe Refractory Chest Pain Following Arrhythmia Ablation.
    J Nucl Cardiol. 2024 Nov 15:102086. doi: 10.1016/j.nuclcard.2024.102086.
    >> Share

  85. TASAKA T, Ogimoto A, Saito M, Koike S, et al
    Assessing the effectiveness of tafamidis therapy in patients with transthyretin cardiac amyloidosis using (99m)technetium pyrophosphate cardiac imaging.
    J Nucl Cardiol. 2024 Nov 8:102075. doi: 10.1016/j.nuclcard.2024.102075.
    >> Share

  86. SATHYAMURTHI B, Sarish S, Khan MA, Arumugam P, et al
    Benefit of 82-Rubidium Positron Emission Tomography for risk stratification in a patient with Intrapericardial diaphragmatic hernia.
    J Nucl Cardiol. 2024 Nov 7:102070. doi: 10.1016/j.nuclcard.2024.102070.
    >> Share

  87. BUILOFF V, Huang C, Kuronuma K, Wei CC, et al
    Automatic motion correction for myocardial blood flow estimation improves diagnostic performance for coronary artery disease in (18)F-flurpiridaz PET-MPI.
    J Nucl Cardiol. 2024 Nov 5:102072. doi: 10.1016/j.nuclcard.2024.102072.
    >> Share

  88. ZHANG X, Yang Y, Pretorius PH, Slomka PJ, et al
    Cardiac motion correction with a deep learning network for perfusion defect assessment in SPECT myocardial perfusion imaging.
    J Nucl Cardiol. 2024 Nov 2:102071. doi: 10.1016/j.nuclcard.2024.102071.
    >> Share

  89. GAO D, Aykac M, Hayden C, Beanlands R, et al
    Rubidium-82 Dose Effects on Myocardial Blood Flow Measurements using a Digital PET-CT Scanner.
    J Nucl Cardiol. 2024 Nov 1:102073. doi: 10.1016/j.nuclcard.2024.102073.
    >> Share

  90. MURTHY VL
    Dawn of the cardiac PET era.
    J Nucl Cardiol. 2024;41:102055.
    >> Share

    October 2024
  91. ROZANSKI A, Gransar H, Miller RJ, Han D, et al
    Clinical Correlates of a Single-item Physical Activity Questionnaire among Patients Undergoing Stress SPECT Myocardial Perfusion Imaging.
    J Nucl Cardiol. 2024 Oct 30:102066. doi: 10.1016/j.nuclcard.2024.102066.
    >> Share

  92. KURONUMA K, Rozanski A, Han D, Park R, et al
    Use of a Single-item Exercise Questionnaire Predicts Prognostic Risk among Patients undergoing Stress PET-MPI.
    J Nucl Cardiol. 2024 Oct 24:102065. doi: 10.1016/j.nuclcard.2024.102065.
    >> Share

  93. KAMEL Y, Terrone D, Pelletier-Galarneau M
    Caseous Calcification as a Cause of False Positive FDG-PET/CT in Native Valve Endocarditis.
    J Nucl Cardiol. 2024 Oct 17:102058. doi: 10.1016/j.nuclcard.2024.102058.
    >> Share

  94. BOBER RM, Milani RV, Abelhad N, Velasco-Gonzalez C, et al
    Fast vs slow rubidium-82 infusion profiles and test-retest precision of myocardial perfusion using contemporary 3D cardiac analog PET-CT imaging.
    J Nucl Cardiol. 2024 Oct 17:102059. doi: 10.1016/j.nuclcard.2024.102059.
    >> Share

  95. GODOY-RIVAS C, Elsadany M, Jaiswal A, Weissler-Snir A, et al
    SPECT/CT Quantification of 99m-TC PYP Uptake to Assess Tafamidis Treatment Response in ATTR Cardiac Amyloidosis.
    J Nucl Cardiol. 2024 Oct 8:102056. doi: 10.1016/j.nuclcard.2024.102056.
    >> Share

  96. ROQUE A, Pizzi MN
    Infection vs inflammation in prosthetic heart valves by [(18)F]FDG-PET/CT: a practical tutorial for accurate interpretation.
    J Nucl Cardiol. 2024 Oct 4:102053. doi: 10.1016/j.nuclcard.2024.102053.
    >> Share

  97. POITRASSON-RIVIERE A, Vanderver MD, Hagio T, Arida-Moody L, et al
    Automated Deep Learning Segmentation of Cardiac Inflammatory FDG PET.
    J Nucl Cardiol. 2024 Oct 3:102052. doi: 10.1016/j.nuclcard.2024.102052.
    >> Share

  98. DI CARLI MF
    Re-imagining risk stratification in high-risk patients: PET and SPECT myocardial perfusion imaging in focus.
    J Nucl Cardiol. 2024;40:102057.
    >> Share

  99. LIGA R, Giorgetti A, Bertasi M, Filidei E, et al
    Myocardial ischemia in patients with mild-to-moderate aortic stenosis: Interaction with cardiac remodeling and adverse events.
    J Nucl Cardiol. 2024;40:102017.
    >> Share

  100. HAGE FG, Bourque JM, Pandey S, Shah NR, et al
    American Society of Nuclear Cardiology quality metrics for cardiac amyloid radionuclide imaging.
    J Nucl Cardiol. 2024;40:102041.
    >> Share

    September 2024
  101. HASHIMOTO H, Kuronuma K, Hyun MC, Han D, et al
    Head-to-head comparison of (18)F-sodium fluoride coronary PET imaging between a silicon photomultiplier with digital photon counting and conventional scanners.
    J Nucl Cardiol. 2024 Sep 27:102045. doi: 10.1016/j.nuclcard.2024.102045.
    >> Share

  102. SUAREZ JP, Dominguez ML, Vigil C, Fernandez B, et al
    Detection of small vegetations in native bi-valvular (aortic + mitral) infective endocarditis with 4D ECG-gated cardiac [(18)F]FDG PET/CT.
    J Nucl Cardiol. 2024 Sep 19:102043. doi: 10.1016/j.nuclcard.2024.102043.
    >> Share

  103. AUER B
    Parametric (82)Rb-Chloride PET Imaging of Myocardial Blood Flow: Ready for Clinical Prime Time?
    J Nucl Cardiol. 2024 Sep 14:102040. doi: 10.1016/j.nuclcard.2024.102040.
    >> Share

  104. ROZANSKI A, Berman D
    Evaluating the Prognostic Effectiveness of Stress SPECT versus PET Myocardial Perfusion Imaging.
    J Nucl Cardiol. 2024 Sep 12:102038. doi: 10.1016/j.nuclcard.2024.102038.
    >> Share

  105. JOHNSON NP, Gould KL
    How to differentiate obstructive from non-obstructive CAD with quantitative PET MPI using Coronary Flow Capacity.
    J Nucl Cardiol. 2024 Sep 10:102039. doi: 10.1016/j.nuclcard.2024.102039.
    >> Share

  106. DI CARLI MF
    Caravan of dreams: Precision quantitative imaging shaping the future of nuclear cardiology.
    J Nucl Cardiol. 2024;39:102044.
    >> Share

  107. TRAVIN MI
    Enhancing the utility of radionuclide adrenergic imaging for assessing the risk of sudden arrhythmic cardiac death.
    J Nucl Cardiol. 2024;39:102022.
    >> Share

  108. VIJAYAKUMAR S, Pabon AR, Clerc OF, Cuddy SAM, et al
    Quantitative (99m)Tc-pyrophosphate myocardial uptake: Changes on transthyretin stabilization therapy.
    J Nucl Cardiol. 2024;39:102019.
    >> Share

    August 2024
  109. KAUR S, Chamseddine F, Abadie B, Sunder V, et al
    Regional Variation in Technetium Pyrophosphate (PYP) Uptake in Transthyretin Cardiac Amyloidosis (ATTR-CA) and Concomitant Myocardial Infarction: A Case Series.
    J Nucl Cardiol. 2024 Aug 29:102031. doi: 10.1016/j.nuclcard.2024.102031.
    >> Share

  110. AL-MALLAH M, Alwan M, Al Rifai M, Sayed A, et al
    Cardiac Positron Emission Tomography and Other Modalities for CAD Assessment: A Snapshot from the Medicare Data.
    J Nucl Cardiol. 2024 Aug 27:102030. doi: 10.1016/j.nuclcard.2024.102030.
    >> Share

  111. PIZZI MN
    Does digital PET/CT represent a step forward in the diagnostic accuracy of infective endocarditis?
    J Nucl Cardiol. 2024 Aug 23:102024. doi: 10.1016/j.nuclcard.2024.102024.
    >> Share

  112. LEE JC, Chong JW, Hector BM
    Communication of unexpected nuclear medicine and PET findings is a two-way street.
    J Nucl Cardiol. 2024 Aug 15:102018. doi: 10.1016/j.nuclcard.2024.102018.
    >> Share

  113. HUNTER C, Moulton E, Beanlands R, deKemp R, et al
    Parametric Imaging of Myocardial Blood Flow with (82)Rb PET: An Accuracy and Image Quality Analysis.
    J Nucl Cardiol. 2024 Aug 10:102020. doi: 10.1016/j.nuclcard.2024.102020.
    >> Share

  114. DI CARLI MF
    Targeted molecular imaging of myocardial infarction: One more step in the right direction.
    J Nucl Cardiol. 2024;38:102021.
    >> Share

  115. LU MT, Tawakol A
    Deeper insights from deep learning: Enhanced myocardial perfusion assessments using multimodal artificial intelligence.
    J Nucl Cardiol. 2024;38:102014.
    >> Share

  116. PELLETIER-GALARNEAU M
    Liver failure and myocardial perfusion imaging: Wake up and smell the coffee.
    J Nucl Cardiol. 2024;38:101904.
    >> Share

  117. AL-MALLAH MH, Al Rifai M, Saad JM
    The role of splenic switch-off in assessing vasodilator response: When less is more.
    J Nucl Cardiol. 2024;38:101896.
    >> Share

  118. KITKUNGVAN D, Johnson NP, Roby AE, Mendoza P, et al
    Quantitative myocardial perfusion in liver transplantation candidates: Poorly metabolized caffeine inhibition of vasodilatory stress.
    J Nucl Cardiol. 2024;38:101884.
    >> Share

    July 2024
  119. NOTOHAMIPRODJO S, Scheidhauer K, Eiber M, Yakushev I, et al
    Impact of a dedicated cardiac protocol on diagnosis of infective endocarditis in patients undergoing [(18)F]-FDG-thoracic digital-PET/CT - Effects of expertise level.
    J Nucl Cardiol. 2024 Jul 27:102010. doi: 10.1016/j.nuclcard.2024.102010.
    >> Share

  120. DAHDAL J, Jukema RA, Harms HJ, Cramer MJ, et al
    PET Myocardial Perfusion Imaging: Trends, Challenges, and Opportunities.
    J Nucl Cardiol. 2024 Jul 25:102011. doi: 10.1016/j.nuclcard.2024.102011.
    >> Share

  121. ALI A, Lu Y, Khalaf S, Iliescu C, et al
    Use of Positron Emission Tomography for The Diagnosis of Immune Checkpoint Inhibitor Myocarditis.
    J Nucl Cardiol. 2024 Jul 23:101909. doi: 10.1016/j.nuclcard.2024.101909.
    >> Share

  122. HUA C, Xi XY, Zhang Y, Suo N, et al
    (99m)Tc-HFAPi SPECT Imaging Predicts Left Ventricular Remodeling After Acute Myocardial Infarction.
    J Nucl Cardiol. 2024 Jul 13:101910. doi: 10.1016/j.nuclcard.2024.101910.
    >> Share

  123. HAGEN JM, Zacherl MJ, Brendel M, Clauss S, et al
    Quantitative assessment of cardiac (123)iodo-metaiodobenzylguanidine SPECT/CT in patients with arrhythmogenic right ventricular cardiomyopathy: novel insight in disease monitoring.
    J Nucl Cardiol. 2024 Jul 13:101911. doi: 10.1016/j.nuclcard.2024.101911.
    >> Share

  124. HUCK DM, Divakaran S, Weber B, Brown JM, et al
    COMPARATIVE EFFECTIVENESS OF PET AND SPECT MPI FOR PREDICTING RISK IN PATIENTS WITH CARDIOMETABOLIC DISEASE.
    J Nucl Cardiol. 2024 Jul 10:101908. doi: 10.1016/j.nuclcard.2024.101908.
    >> Share

  125. SHETTY M, Bullock-Palmer RP, Dorbala S, Chareonthaitawee P, et al
    #WINning together: Celebrating American Society of Nuclear Cardiology's women in nuclear cardiology initiative.
    J Nucl Cardiol. 2024;37:101905.
    >> Share

  126. SOMAN P, Hyafil F
    Resting myocardial blood flow: To correct, or not to correct, that is the question!
    J Nucl Cardiol. 2024;37:101902.
    >> Share

  127. DI CARLI MF
    July signals change: Welcoming new editorial voices and key clinical insights.
    J Nucl Cardiol. 2024;37:101906.
    >> Share

  128. MAANIITTY T, Knuuti J
    The additional value of relative assessment of quantitative myocardial blood flow.
    J Nucl Cardiol. 2024;37:101886.
    >> Share

  129. CHIH S, Tavoosi A, Beanlands RSB
    How to use nuclear cardiology to evaluate cardiac allograft vasculopathy.
    J Nucl Cardiol. 2024;37:101866.
    >> Share

  130. HUCK DM, Weber BN, Brown JM, Lopez D, et al
    Prognostic value of myocardial flow reserve vs corrected myocardial flow reserve in patients without obstructive coronary artery disease.
    J Nucl Cardiol. 2024;37:101854.
    >> Share

    June 2024
  131. TEUHO J, Schultz J, Klen R, Juarez-Orozco LE, et al
    Explainable deep learning-based ischemia detection using hybrid O-15 H2O perfusion PET/CT imaging and clinical data.
    J Nucl Cardiol. 2024 Jun 7:101889. doi: 10.1016/j.nuclcard.2024.101889.
    >> Share

  132. SELVARAJ S, Bravo PE
    How to Prepare a Patient for FDG PET Imaging to Assess Myocardial Inflammation.
    J Nucl Cardiol. 2024 Jun 1:101888. doi: 10.1016/j.nuclcard.2024.101888.
    >> Share

  133. DI CARLI MF
    Charting the future of nuclear cardiology: Innovation, creativity, and perseverance.
    J Nucl Cardiol. 2024;36:101890.
    >> Share

  134. KERR N, Miller RJH, Chew DS
    Can nuclear cardiology optimize cardiac resynchronization therapy lead placement: Paving the way to precision medicine?
    J Nucl Cardiol. 2024;36:101873.
    >> Share

  135. LIM P, Agarwal V, Patel KK
    How to assess nonresponsiveness to vasodilator stress.
    J Nucl Cardiol. 2024;36:101850.
    >> Share

    May 2024
  136. JUAREZ-OROZCO LE
    Exploring PET-derived geometric indexes in ischemic heart disease - Is more in store?
    J Nucl Cardiol. 2024 May 15:101883. doi: 10.1016/j.nuclcard.2024.101883.
    >> Share

  137. ROQUE A, Pizzi MN
    PET/CT in aortic grafts: sufficient evidence or still leap of faith?
    J Nucl Cardiol. 2024 May 9:101882. doi: 10.1016/j.nuclcard.2024.101882.
    >> Share

  138. MANABE O, Tamaki N
    Revealing the Hidden Depths of Takotsubo Syndrome: The Crucial Role of PET in Understanding and Managing Cardiac Microvascular Dysfunction.
    J Nucl Cardiol. 2024 May 7:101878. doi: 10.1016/j.nuclcard.2024.101878.
    >> Share

  139. ZHANG Y, Bos E, Clarkin O, Wilson T, et al
    Interpretation of SPECT Wall Motion with Deep Learning.
    J Nucl Cardiol. 2024 May 7:101881. doi: 10.1016/j.nuclcard.2024.101881.
    >> Share

  140. MARK PD, Prescott E, Marner L, Hovind P, et al
    [(15)O]H(2)O myocardial perfusion PET: Added value of relative stress perfusion deficit in the prediction of significant coronary artery stenosis in a mixed population.
    J Nucl Cardiol. 2024 May 4:101880. doi: 10.1016/j.nuclcard.2024.101880.
    >> Share

  141. DECORADS CE, Lambert A, Roch V, Imbert L, et al
    Association between baseline hemodynamic indices, cardiotoxicity risk, and survival in women with breast cancer.
    J Nucl Cardiol. 2024;35:101849.
    >> Share

    April 2024
  142. SI H, He Z, Malhotra S, Zhang X, et al
    A novel method combining gated SPECT and vectorcardiography to guide left ventricular lead placement to improve response to cardiac resynchronization therapy: A Proof of Concept study.
    J Nucl Cardiol. 2024 Apr 30:101867. doi: 10.1016/j.nuclcard.2024.101867.
    >> Share

  143. BRORSON J, Gormsen LC, Madsen S, Tolbod LP, et al
    Splenic switch-off in [(15)O]H(2)O-PET myocardial perfusion imaging using parametric blood flow images.
    J Nucl Cardiol. 2024 Apr 27:101868. doi: 10.1016/j.nuclcard.2024.101868.
    >> Share

  144. KADOYA Y, Chong AY, Small GR, Chow B, et al
    Myocardial flow reserve recovery in patients with Takotsubo syndrome: insights from positron emission tomography.
    J Nucl Cardiol. 2024 Apr 27:101869. doi: 10.1016/j.nuclcard.2024.101869.
    >> Share

  145. HASSE B, Ledergerber B, Van Hemelrijck M, Frank M, et al
    FDG uptake patterns in PET/CT caused by inflammation and/or infection after graft surgery for thoracic aortic dissection.
    J Nucl Cardiol. 2024 Apr 26:101865. doi: 10.1016/j.nuclcard.2024.101865.
    >> Share

  146. MARTINEZ-LUCIO TS, Alexanderson-Rosas E, Carvajal-Juarez I, Mendoza-Ibanez AK, et al
    Left ventricular shape index and eccentricity index with ECG-gated Nitrogen-13 ammonia PET/CT in patients with myocardial infarction, ischemia and normal perfusion.
    J Nucl Cardiol. 2024 Apr 10:101862. doi: 10.1016/j.nuclcard.2024.101862.
    >> Share

  147. SPERRY BW, Vuppala S
    Sequential FDG PET Imaging in Cardiac Sarcoidosis.
    J Nucl Cardiol. 2024 Apr 5:101860. doi: 10.1016/j.nuclcard.2024.101860.
    >> Share

    March 2024
  148. TAVOOSI A, Paquin A, deKemp R, Chong AY, et al
    POSITRON EMISSION TOMOGRAPHY ASSESSMENT OF CORONARY MICROVASCULAR ANGINA IN PATIENTS WITH ANGINA AND NONOBSTRUCTIVE CORONARY ARTERY DISEASE.
    J Nucl Cardiol. 2024 Mar 25:101853. doi: 10.1016/j.nuclcard.2024.101853.
    >> Share

  149. ABU-QAMAR O, Biery DW, Mendonca LSM, Barrett L, et al
    Association between Abnormal Retinal Perfusion Indices by Optical Coherence Tomography Angiography and Myocardial Flow Reserve by PET/CT.
    J Nucl Cardiol. 2024 Mar 25:101852. doi: 10.1016/j.nuclcard.2024.101852.
    >> Share

  150. BALMFORTH C, Whittington B, Tzolos E, Bing R, et al
    Translational Molecular imaging: Thrombosis Imaging with Positron Emission Tomography.
    J Nucl Cardiol. 2024 Mar 16:101848. doi: 10.1016/j.nuclcard.2024.101848.
    >> Share

  151. KWIECINSKI J
    Role of (18)F-sodium fluoride positron emission tomography in imaging atherosclerosis.
    J Nucl Cardiol. 2024 Mar 11:101845. doi: 10.1016/j.nuclcard.2024.101845.
    >> Share

  152. OKAFOR J, Khattar R, Kouranos V, Ohri S, et al
    Role of serial (18)FDG-PET in determining the therapeutic efficacy of immunosuppression and clinical outcome in patients with cardiac sarcoidosis.
    J Nucl Cardiol. 2024 Mar 11:101842. doi: 10.1016/j.nuclcard.2024.101842.
    >> Share

  153. RUDDY TD, Wells RG
    Shortening the Acquisition Times of CZT SPECT Imaging for Measurement of Myocardial Blood Flow.
    J Nucl Cardiol. 2024 Mar 9:101847. doi: 10.1016/j.nuclcard.2024.101847.
    >> Share

  154. DI CARLI MF
    How is PET/CT Imaging Revolutionizing Cardiac Care: Let me Count the Ways.
    J Nucl Cardiol. 2024 Mar 7:101844. doi: 10.1016/j.nuclcard.2024.101844.
    >> Share

  155. PATEL KK, Singh A, Qarajeh R, Shatla I, et al
    Prevalence of Balanced Ischemia on PET Relative Perfusion Imaging Among Patients with High-Risk Coronary Artery Disease.
    J Nucl Cardiol. 2024 Mar 2:101836. doi: 10.1016/j.nuclcard.2024.101836.
    >> Share

  156. BOBER RM, Johnson NP
    How might coronary sinus reducer treatment change myocardial perfusion?
    J Nucl Cardiol. 2024;33:101828.
    >> Share

  157. AL RIFAI M, Winchester D
    When should myocardial perfusion imaging be a first-test choice?
    J Nucl Cardiol. 2024;33:101824.
    >> Share

  158. ZAMPELLA E, Assante R, Acampa W
    A good assist is followed by a goal.
    J Nucl Cardiol. 2024;33:101807.
    >> Share

  159. AKSIT E, Kirilmaz B, Ozdemir S
    The importance of myocardial perfusion imaging in patients with ischemia and nonobstructive coronary arteries.
    J Nucl Cardiol. 2024;33:101791.
    >> Share

    February 2024
  160. SOLANKI R, Singh H, Mehta V, Panda P, et al
    Potential application of (68)Ga-FAPI PET/CT for diagnosing cardiac sarcoidosis.
    J Nucl Cardiol. 2024 Feb 23:101835. doi: 10.1016/j.nuclcard.2024.101835.
    >> Share

  161. SEVAG PACKARD RR
    Expanding the Repertoire of (18)F-Labeled PET MPI Radiotracers.
    J Nucl Cardiol. 2024 Feb 23:101834. doi: 10.1016/j.nuclcard.2024.101834.
    >> Share

  162. LIU A, Cain L, Munemo LT, Ahmed R, et al
    Characterisation and management of expected and unexpected urgent findings from FDG-PET-CT in cardiovascular disease.
    J Nucl Cardiol. 2024 Feb 20:101826. doi: 10.1016/j.nuclcard.2024.101826.
    >> Share

  163. WANG J, Chen Y, Chu H, Pang Z, et al
    Feasibility of Myocardial Blood Flow Quantification to Detect Flow-limited Coronary Artery Disease with A One-day Rest/Stress Continuous Rapid Imaging Protocol on Cardiac-dedicated CZT SPECT.
    J Nucl Cardiol. 2024 Feb 20:101825. doi: 10.1016/j.nuclcard.2024.101825.
    >> Share

  164. REN C, Pan Q, Fu C, Wang P, et al
    Phase I, first-in-human study of XTR004, a novel (18)F-labeled tracer for myocardial perfusion PET: biodistribution, radiation dosimetry, pharmacokinetics and safety after a single injection at rest.
    J Nucl Cardiol. 2024 Feb 13:101823. doi: 10.1016/j.nuclcard.2024.101823.
    >> Share

  165. BOURQUE JM, Birgersdotter-Green U, Bravo PE, Budde RPJ, et al
    (18)F-FDG PET/CT and radiolabeled leukocyte SPECT/CT imaging for the evaluation of cardiovascular infection in the multimodality context: ASNC Imaging Indications (ASNC I(2)) Series Expert Consensus Recommendations from ASNC, AATS, ACC, AHA, ASE, EANM
    J Nucl Cardiol. 2024 Feb 12:101786. doi: 10.1016/j.nuclcard.2023.101786.
    >> Share

  166. DI CARLI MF
    Navigating the positron emission tomography vs. single-photon emission computed tomography debate: A closer look at evidence and guidelines.
    J Nucl Cardiol. 2024 Feb 2:101822. doi: 10.1016/j.nuclcard.2024.101822.
    >> Share

    January 2024
  167. BHATTARU A, Rojulpote C, Vidula M, Duda J, et al
    Deep Learning Approach for Automated Segmentation of Myocardium Using Bone Scintigraphy SPECT/CT in Patients with Suspected Cardiac Amyloidosis.
    J Nucl Cardiol. 2024 Jan 31:101809. doi: 10.1016/j.nuclcard.2024.101809.
    >> Share

  168. HAN Y, Ahmed AI, Saad JM, Alahdab F, et al
    Ejection Fraction And Ventricular Volumes On Rubidium Positron Emission Tomography: Prospective Validation Against Cardiovascular Magnetic Resonance.
    J Nucl Cardiol. 2024 Jan 27:101810. doi: 10.1016/j.nuclcard.2024.101810.
    >> Share

  169. FUJIOKA K, Norikane T, Takami Y, Yamamoto Y, et al
    Feasibility of PiB PET/CT for treatment monitoring with Tafamidis in a patient with ATTR-CA.
    J Nucl Cardiol. 2024 Jan 19:101816. doi: 10.1016/j.nuclcard.2024.101816.
    >> Share

  170. DIETZ M, Bochaton T, Al Mansour L, Tordo J, et al
    Identification of lipomatous metaplasia on CT images helps confirm prior silent myocardial infarction associated with equivocal perfusion abnormality on SPECT/CT imaging.
    J Nucl Cardiol. 2024 Jan 19:101812. doi: 10.1016/j.nuclcard.2024.101812.
    >> Share

  171. WILLIAMS MC
    Machine learning models for PET myocardial perfusion imaging.
    J Nucl Cardiol. 2024 Jan 18:101805. doi: 10.1016/j.nuclcard.2024.101805.
    >> Share

  172. ROZANSKI A, Miller RJH, Han D, Gransar H, et al
    Comparative Predictors of Mortality among Patients Referred for Stress SPECT versus PET Myocardial Perfusion Imaging.
    J Nucl Cardiol. 2024 Jan 18:101811. doi: 10.1016/j.nuclcard.2024.101811.
    >> Share

  173. CHENG K, Tan ST, Wechalekar K, Keramida G, et al
    Redistribution of myocardial perfusion after coronary sinus reducer implantation demonstrated by rubidium-82 positron emission tomography.
    J Nucl Cardiol. 2024 Jan 12:101803. doi: 10.1016/j.nuclcard.2024.101803.
    >> Share

  174. SANGHANI R, Al-Mallah MH, Thompson R
    Challenges and Strategies to enable access to Cardiac PET in Different Parts of the World: The North American Perspective.
    J Nucl Cardiol. 2024 Jan 10:101790. doi: 10.1016/j.nuclcard.2023.101790.
    >> Share

  175. BORGES-ROSA J, Oliveira-Santos M, Silva R, Elvas L, et al
    (18)F-FDG PET-CT FOR DIAGNOSING CUTANEOUS FISTULAS SECONDARY TO RETAINED LEAD FRAGMENTS: A RARE AND CHALLENGING COMPLICATION AFTER PACEMAKER EXTRACTION.
    J Nucl Cardiol. 2024 Jan 6:101794. doi: 10.1016/j.nuclcard.2024.101794.
    >> Share

  176. BAILLY M, Gamet A, Metrard G
    Potential utility of myocardial blood flow quantification with SPECT in a patient undergoing treatment for breast cancer.
    J Nucl Cardiol. 2024 Jan 5:101799. doi: 10.1016/j.nuclcard.2024.101799.
    >> Share

  177. FUJIOKA K, Norikane T, Takami Y, Yamamoto Y, et al
    Feasibility of PiB PET/CT for treatment monitoring with Tafamidis in a patient with ATTR-CA.
    J Nucl Cardiol. 2024 Jan 5:101800. doi: 10.1016/j.nuclcard.2024.101800.
    >> Share

  178. BERMAN D, Hunter C, Hossain A, Yao J, et al
    Machine and deep learning models for accurate detection of ischemia and scar with myocardial blood flow PET imaging.
    J Nucl Cardiol. 2024 Jan 5:101797. doi: 10.1016/j.nuclcard.2024.101797.
    >> Share

  179. GAEMPERLI O
    Ejection fraction and ventricular volumes on Rb PET: Validation against cardiovascular MRI.
    J Nucl Cardiol. 2024 Jan 4:101795. doi: 10.1016/j.nuclcard.2024.101795.
    >> Share

  180. HOFF CM, Sorensen J, Kero T, Bouchelouche K, et al
    Quantitative and qualitative comparison of Rubidium-82 and Oxygen-15 water cardiac PET.
    J Nucl Cardiol. 2024 Jan 4:101796. doi: 10.1016/j.nuclcard.2024.101796.
    >> Share

  181. ABAZID RM, Davey RA, Romsa J, Florendo-Cumbermack A, et al
    Progressive development of cardiac amyloidosis in a hereditary transthyretin gene carrier on serial Tc-99m PYP SPECT-CT.
    J Nucl Cardiol. 2024;31:101774.
    >> Share

  182. CROWLEY A, Gerson M
    The future of PET imaging: Looking forward to more choices and increased precision with the use of oxygen-15 water.
    J Nucl Cardiol. 2024;31:101775.
    >> Share

  183. SUERO-ABREU GA, Lim P, Raza A, Tysarowski M, et al
    Effect of variable left ventricular ejection fraction assessed by equilibrium radionuclide angiocardiography using different software packages on the diagnosis of cardiotoxicity in patients with cancer.
    J Nucl Cardiol. 2024;31:101782.
    >> Share

  184. DI CARLI MF, Gormsen LC, Chareonthaitawee P, Johnson GB, et al
    Rationale and design of the RAPID-WATER-FLOW trial: Radiolabeled perfusion to identify coronary artery disease using water to evaluate responses of myocardial FLOW.
    J Nucl Cardiol. 2024;31:101779.
    >> Share

    December 2023
  185. ARUMUGAM P, Better N, Keng FY, Allam A, et al
    Current state and challenges of implementing a cardiac positron emission tomography program outside North America.
    J Nucl Cardiol. 2023;31:101788.
    >> Share

  186. DANAD I, Driessen RS
    Utility of (82)Rb and [(15)O]H(2)O PET myocardial perfusion imaging in challenging (high risk) patients: "Don't throw the baby out with the bathwater".
    J Nucl Cardiol. 2023 Dec 2:101783. doi: 10.1016/j.nuclcard.2023.101783.
    >> Share

  187. HUDSON O, Hage FG
    Single photon emission computed tomography pyrophosphate imaging for transthyretin cardiac amyloid.
    J Nucl Cardiol. 2023;30:2615-2617.
    >> Share

  188. ROZANSKI A, Gransar H, Sakul S, Miller RJH, et al
    Increasing frequency of dyspnea among patients referred for cardiac stress testing.
    J Nucl Cardiol. 2023;30:2303-2313.
    >> Share

  189. AL-MALLAH MH
    ASNC without borders: A global effort in nuclear cardiology.
    J Nucl Cardiol. 2023;30:2972-2975.
    >> Share

  190. NAKAJIMA K, Shibutani T, Massanes F, Shimizu T, et al
    Myocardial perfusion imaging with retrospective gating and integrated correction of attenuation, scatter, respiration, motion, and arrhythmia.
    J Nucl Cardiol. 2023;30:2773-2789.
    >> Share

  191. LI L, Gao J, Chen BX, Liu X, et al
    Fibroblast activation protein imaging in atrial fibrillation: a proof-of-concept study.
    J Nucl Cardiol. 2023;30:2712-2720.
    >> Share

  192. MATTHEWS B, Duddleston D, Hage FG
    Myocardial perfusion imaging in congenitally corrected transposition of the great arteries.
    J Nucl Cardiol. 2023;30:2907-2910.
    >> Share

  193. YU W, Yang L, Zhang F, Liu B, et al
    Machine learning to predict hemodynamically significant CAD based on traditional risk factors, coronary artery calcium and epicardial fat volume.
    J Nucl Cardiol. 2023;30:2593-2606.
    >> Share

  194. LASSEN ML, Byrne C, Hartmann JP, Kjaer A, et al
    Pulmonary blood volume assessment from a standard cardiac rubidium-82 imaging protocol: impact of adenosine-induced hyperemia.
    J Nucl Cardiol. 2023;30:2504-2513.
    >> Share

  195. SCIAGRA R, Linguanti F
    The Never-ending Story: Assessing coronary collateral circulation with myocardial perfusion imaging.
    J Nucl Cardiol. 2023;30:2346-2348.
    >> Share

  196. REID BJ, Lindow T, Warren S, Persson E, et al
    Immediate recruitment of dormant coronary collaterals can provide more than half of normal resting perfusion during coronary occlusion in patients with coronary artery disease.
    J Nucl Cardiol. 2023;30:2338-2345.
    >> Share

  197. PRETORIUS PH, Liu J, Kalluri KS, Jiang Y, et al
    Observer studies of image quality of denoising reduced-count cardiac single photon emission computed tomography myocardial perfusion imaging by three-dimensional Gaussian post-reconstruction filtering and deep learning.
    J Nucl Cardiol. 2023;30:2427-2437.
    >> Share

  198. DAWDY J, Polina A, Abidov A
    Ascites and liver cirrhosis diagnosed on cardiac scintigraphic imaging.
    J Nucl Cardiol. 2023;30:2837-2838.
    >> Share

  199. MANNARINO T, D'Antonio A, Assante R, Zampella E, et al
    Combined evaluation of CAC score and myocardial perfusion imaging in patients at risk of cardiovascular disease: where are we and what do the data say.
    J Nucl Cardiol. 2023;30:2349-2360.
    >> Share

  200. SUBRAMANIAN K, Mittal BR, Singh H, Sood A, et al
    Stigmata of portal hypertension depicted on myocardial perfusion imaging.
    J Nucl Cardiol. 2023;30:2813-2815.
    >> Share

  201. RAVAL M, Siddiq S
    Extra-cardiac uptake of 99mTc-pyrophosphate scan leading to the diagnosis of stage IV metastatic prostatic adenocarcinoma.
    J Nucl Cardiol. 2023;30:2807-2808.
    >> Share

  202. SUBRAMANIAN K, Mahdi R, Singh H, Sood A, et al
    Perfusion defect with characteristic anterior wall indentation on myocardial perfusion imaging caused by a large left ventricular aneurysm.
    J Nucl Cardiol. 2023;30:2809-2812.
    >> Share

  203. YAGHOOBI N, Maghsudi M, Malek H, Bakhshandeh H, et al
    Role of CT attenuation correction gated SPECT MPI in prediction of pulmonary hypertension.
    J Nucl Cardiol. 2023;31:101777.
    >> Share

  204. MATTHEWS B, Duddleston D, Hage FG
    Myocardial perfusion imaging in congenitally corrected transposition of the great arteries.
    J Nucl Cardiol. 2023;30:2907-2910.
    >> Share

  205. BUTT F, Siegel A
    Acute intramural hematoma of the ascending aorta discovered on myocardial perfusion SPECT.
    J Nucl Cardiol. 2023;30:2841-2843.
    >> Share

  206. SILLANMAKI S, Iso-Mustajarvi S
    (18)F-FDG-PET of cardiac sarcoidosis with subcutaneous nodules.
    J Nucl Cardiol. 2023;30:2839-2840.
    >> Share

  207. DAWDY J, Polina A, Abidov A
    Ascites and liver cirrhosis diagnosed on cardiac scintigraphic imaging.
    J Nucl Cardiol. 2023;30:2837-2838.
    >> Share

  208. SUBRAMANIAN K, Bahl A, Singh H, Singh H, et al
    Invasive cardiac aspergillosis in an immuno-competent patient: distinctive imaging features on 18F-fluorodeoxyglucose (FDG)-PET/CT and 99mTc-sestamibi SPECT myocardial perfusion imaging.
    J Nucl Cardiol. 2023;30:2825-2827.
    >> Share

  209. KAUR S, Bartley P, Gordon S, Higgins A, et al
    Left ventricular assist device infection on (18)F-flourodeoxyglucose positron emission tomography.
    J Nucl Cardiol. 2023;30:2823-2824.
    >> Share

  210. YAMAMOTO A, Nagao M, Inai K, Shinkawa T, et al
    Coronary microvascular dysfunction detected by (13)N-ammonia positron emission tomography in a patient with repaired aortic coarctation.
    J Nucl Cardiol. 2023;30:2819-2822.
    >> Share

  211. SUBRAMANIAN K, Mittal BR, Singh H, Sood A, et al
    Stigmata of portal hypertension depicted on myocardial perfusion imaging.
    J Nucl Cardiol. 2023;30:2813-2815.
    >> Share

  212. SUBRAMANIAN K, Mahdi R, Singh H, Sood A, et al
    Perfusion defect with characteristic anterior wall indentation on myocardial perfusion imaging caused by a large left ventricular aneurysm.
    J Nucl Cardiol. 2023;30:2809-2812.
    >> Share

  213. RAVAL M, Siddiq S
    Extra-cardiac uptake of 99mTc-pyrophosphate scan leading to the diagnosis of stage IV metastatic prostatic adenocarcinoma.
    J Nucl Cardiol. 2023;30:2807-2808.
    >> Share

  214. FITCH JS, Schwartz RG
    Detection and quantification of myocardial scar and LVEF with high efficiency digital SPECT: The expanding value proposition for clinical cardiology.
    J Nucl Cardiol. 2023;30:2803-2806.
    >> Share

  215. KRAKAUER M, Ismail A, Talleruphuus U, Henriksen AC, et al
    (82)Rb and [(15)O]H(2)O myocardial perfusion PET imaging: a prospective head to head comparison.
    J Nucl Cardiol. 2023;30:2790-2802.
    >> Share

  216. NAKAJIMA K, Shibutani T, Massanes F, Shimizu T, et al
    Myocardial perfusion imaging with retrospective gating and integrated correction of attenuation, scatter, respiration, motion, and arrhythmia.
    J Nucl Cardiol. 2023;30:2773-2789.
    >> Share

  217. JAHANDIDEH A, Virta J, Li XG, Liljenback H, et al
    Vascular adhesion protein-1-targeted PET imaging in autoimmune myocarditis.
    J Nucl Cardiol. 2023;30:2760-2772.
    >> Share

  218. JUAREZ-OROZCO LE, Niemi M, Yeung MW, Benjamins JW, et al
    Hybridizing machine learning in survival analysis of cardiac PET/CT imaging.
    J Nucl Cardiol. 2023;30:2750-2759.
    >> Share

  219. CHRISTENSEN NL, Nordstrom J, Madsen S, Madsen MA, et al
    Detection and correction of patient motion in dynamic (15)O-water PET MPI.
    J Nucl Cardiol. 2023;30:2736-2749.
    >> Share

  220. WATANABE S, Nakajima K, Toshima F, Wakabayashi H, et al
    Transthyretin amyloid cardiomyopathy disease burden quantified using (99m)Tc-pyrophosphate SPECT/CT: volumetric parameters versus SUVmax ratio at 1 and 3 hours.
    J Nucl Cardiol. 2023;30:2721-2735.
    >> Share

  221. LI L, Gao J, Chen BX, Liu X, et al
    Fibroblast activation protein imaging in atrial fibrillation: a proof-of-concept study.
    J Nucl Cardiol. 2023;30:2712-2720.
    >> Share

  222. DE OLIVEIRA RS, Moll-Bernardes R, de Brito AX, Pinheiro MVT, et al
    Use of PET/CT to detect myocardial inflammation and the risk of malignant arrhythmia in chronic Chagas disease.
    J Nucl Cardiol. 2023;30:2702-2711.
    >> Share

  223. KAMERMAN M, van Dijk JD, Timmer JR, Ottervanger JP, et al
    The incremental value of coronary artery calcium score in predicting long-term prognosis and defining the warranty period of normal adenosine stress-only myocardial perfusion imaging using CZT SPECT.
    J Nucl Cardiol. 2023;30:2692-2701.
    >> Share

  224. ARNFIELD EG, Tam L, Pattison DA, Younger J, et al
    Cardiac metastases from neuroendocrine neoplasms: complementary role of SSTR PET/CT and cardiac MRI.
    J Nucl Cardiol. 2023;30:2676-2691.
    >> Share

  225. SAN MIGUEL L, Goldschmidt E, Brisbin AK, Redruello M, et al
    A new perspective on an old method: gated SPECT imaging for left ventricular contractile function assessment.
    J Nucl Cardiol. 2023;30:2658-2665.
    >> Share

  226. CAMONI L, Dondi F
    Time-efficient cardiac imaging: early post-injection stress-first protocol myocardial perfusion SPECT with a CZT camera.
    J Nucl Cardiol. 2023;30:2655-2657.
    >> Share

  227. CASE JA, Courter SA, McGhie A, Patel KK, et al
    Accurate and efficient rapid acquisition early post-injection stress-first CZT SPECT myocardial perfusion imaging with tetrofosmin and attenuation correction.
    J Nucl Cardiol. 2023;30:2644-2654.
    >> Share

  228. GRAMBOW-VELILLA J, Mahida B, Benali K, Deconinck L, et al
    Prognosis and follow-up of patients with prosthetic valve endocarditis treated conservatively in relation to WBC-SPECT imaging.
    J Nucl Cardiol. 2023;30:2633-2643.
    >> Share

  229. ZHANG J, Xie J, Li M, Fang W, et al
    SPECT myocardial blood flow quantitation for the detection of angiographic stenoses with cardiac-dedicated CZT SPECT.
    J Nucl Cardiol. 2023;30:2618-2632.
    >> Share

  230. HUDSON O, Hage FG
    Single photon emission computed tomography pyrophosphate imaging for transthyretin cardiac amyloid.
    J Nucl Cardiol. 2023;30:2615-2617.
    >> Share

  231. AKINCIOGLU C, Murthi M, Romsa J, Warrington J, et al
    Comparison of cardio-focal and chest reconstruction of technetium-99m pyrophosphate scintigraphy for diagnosis of transthyretin cardiac amyloidosis: a quality assurance study.
    J Nucl Cardiol. 2023;30:2607-2614.
    >> Share

  232. YU W, Yang L, Zhang F, Liu B, et al
    Machine learning to predict hemodynamically significant CAD based on traditional risk factors, coronary artery calcium and epicardial fat volume.
    J Nucl Cardiol. 2023;30:2593-2606.
    >> Share

  233. LI L, Pang Z, Wang J, Chen Y, et al
    Prognostic value of myocardial flow reserve measured with CZT cardiac-dedicated SPECT low-dose dynamic myocardial perfusion imaging in patients with INOCA.
    J Nucl Cardiol. 2023;30:2578-2592.
    >> Share

  234. CLERC OF, Frey SM, Honegger U, Amrein MLF, et al
    Coronary artery calcium score and pre-test probabilities as gatekeepers to predict and rule out perfusion defects in positron emission tomography.
    J Nucl Cardiol. 2023;30:2559-2573.
    >> Share

  235. SAZONOVA SI, Ilyushenkova JN, Syrkina AG, Trusov AA, et al
    Potential utility of SPECT/CT with 99mTc-Tektrotyd for imaging of post-myocardial infarction inflammation.
    J Nucl Cardiol. 2023;30:2544-2555.
    >> Share

  236. KHOR YM, Dorbala S
    Extra-cardiac uptake on technetium-99m pyrophosphate (Tc-99m PYP) scan: not just a matter of the heart.
    J Nucl Cardiol. 2023;30:2540-2543.
    >> Share

  237. KHERAJANI P, Farag AA, Morgan WS, Hage FG, et al
    Complete resolution of focal-on-diffuse myocardial activity pattern on FDG PET-CT by prolonging the dietary preparation protocol in cardiac sarcoidosis.
    J Nucl Cardiol. 2023;30:2525-2530.
    >> Share

  238. ADHADUK M, Paudel B, Liu K, Ashwath M, et al
    Comparison of cardiac magnetic resonance imaging and fluorodeoxyglucose positron emission tomography in the assessment of myocardial viability: meta-analysis and systematic review.
    J Nucl Cardiol. 2023;30:2514-2524.
    >> Share

  239. LASSEN ML, Byrne C, Hartmann JP, Kjaer A, et al
    Pulmonary blood volume assessment from a standard cardiac rubidium-82 imaging protocol: impact of adenosine-induced hyperemia.
    J Nucl Cardiol. 2023;30:2504-2513.
    >> Share

  240. JOHN LA, Tedrow UB, Divakaran S
    Can FDG PET/CT predict AV nodal recovery in cardiac sarcoidosis?
    J Nucl Cardiol. 2023;30:2501-2503.
    >> Share

  241. LUCINIAN YA, Martineau P, Poenaru R, Tremblay-Gravel M, et al
    FDG-PET/CT and rest myocardial perfusion imaging to predict high-degree atrioventricular block recovery in cardiac sarcoidosis.
    J Nucl Cardiol. 2023;30:2490-2500.
    >> Share

  242. TAVOOSI A, Khetarpal R, Wells RG, Beanlands RSB, et al
    Exponential dosing to standardize myocardial perfusion image quality with rubidium-82 PET.
    J Nucl Cardiol. 2023;30:2477-2489.
    >> Share

  243. AHLUWALIA N, Roshankar G, Draycott L, Jimenez-Zepeda V, et al
    Diagnostic accuracy of bone scintigraphy imaging for transthyretin cardiac amyloidosis: systematic review and meta-analysis.
    J Nucl Cardiol. 2023;30:2464-2476.
    >> Share

  244. CHAN SH, Huang CK, Luzhbin D, Hou PN, et al
    Meta-analysis of the effectiveness of heparin in suppressing physiological myocardial FDG uptake in PET/CT.
    J Nucl Cardiol. 2023;30:2454-2463.
    >> Share

  245. PRETORIUS PH, Liu J, Kalluri KS, Jiang Y, et al
    Observer studies of image quality of denoising reduced-count cardiac single photon emission computed tomography myocardial perfusion imaging by three-dimensional Gaussian post-reconstruction filtering and deep learning.
    J Nucl Cardiol. 2023;30:2427-2437.
    >> Share

  246. HANSEN CL
    Improving evaluation for TTR amyloidosis by interactive filtering of Tc-99 m PYP SPECT images. The role for "clean blood pool" imaging.
    J Nucl Cardiol. 2023;30:2418-2426.
    >> Share

  247. SAG SJM, Menhart K, Hitzenbichler F, Schmid C, et al
    (18)F-FDG PET/CT-derived total lesion glycolysis predicts abscess formation in patients with surgically confirmed infective endocarditis: Results of a retrospective study at a tertiary center.
    J Nucl Cardiol. 2023;30:2400-2414.
    >> Share

  248. KITAGAWA T, Sasaki K, Fujii Y, Ikegami Y, et al
    (18)F-sodium fluoride positron emission tomography following coronary computed tomography angiography in predicting long-term coronary events: a 5-year follow-up study.
    J Nucl Cardiol. 2023;30:2365-2378.
    >> Share

  249. MANNARINO T, D'Antonio A, Assante R, Zampella E, et al
    Combined evaluation of CAC score and myocardial perfusion imaging in patients at risk of cardiovascular disease: where are we and what do the data say.
    J Nucl Cardiol. 2023;30:2349-2360.
    >> Share

  250. SCIAGRA R, Linguanti F
    The Never-ending Story: Assessing coronary collateral circulation with myocardial perfusion imaging.
    J Nucl Cardiol. 2023;30:2346-2348.
    >> Share

  251. PICCINELLI M, Cooke CD, Folks R, Garcia EV, et al
    4D display of CT LV endocardial and epicardial models morphed from PET Rb-82 perfusion studies accurately quantifies segmental myocardial thickening.
    J Nucl Cardiol. 2023;30:2314-2326.
    >> Share

  252. ROZANSKI A, Gransar H, Sakul S, Miller RJH, et al
    Increasing frequency of dyspnea among patients referred for cardiac stress testing.
    J Nucl Cardiol. 2023;30:2303-2313.
    >> Share

  253. LIMA BB, Benz DC
    Casting aside the creep: harnessing cardiorespiratory dynamics to optimize myocardial flow assessment in cardiac PET.
    J Nucl Cardiol. 2023;30:2301-2302.
    >> Share

  254. LASSEN ML, Rasmussen T, Byrne C, Holmvang L, et al
    Myocardial creep and cardiorespiratory motion correction improves diagnostic accuracy of Rubidium-82 cardiac positron emission tomography.
    J Nucl Cardiol. 2023;30:2289-2300.
    >> Share

  255. BATEMAN TM
    In 2023 PET myocardial perfusion imaging is preferred to invasive coronary angiography for the initial work-up of a symptomatic patient with a high coronary artery calcium score.
    J Nucl Cardiol. 2023;30:2273-2278.
    >> Share

  256. JOHNSRUD DO, Port SC
    In 2023 invasive coronary angiography is preferred to PET myocardial perfusion imaging for the initial work-up of a symptomatic patient with a high coronary artery calcium score.
    J Nucl Cardiol. 2023;30:2269-2272.
    >> Share

    November 2023
  257. BATEMAN TM
    In 2023 PET myocardial perfusion imaging is preferred to invasive coronary angiography for the initial work-up of a symptomatic patient with a high coronary artery calcium score.
    J Nucl Cardiol. 2023 Nov 10. doi: 10.1007/s12350-023-03386.
    >> Share

  258. KAMERMAN M, van Dijk JD, Timmer JR, Ottervanger JP, et al
    Correction to: The incremental value of coronary artery calcium score in predicting long-term prognosis and defining the warranty period of normal adenosine stress-only myocardial perfusion imaging using CZT SPECT.
    J Nucl Cardiol. 2023 Nov 6. doi: 10.1007/s12350-023-03389.
    >> Share

    October 2023
  259. CHAREONTHAITAWEE P, Bateman TM, Beanlands RS, Berman DS, et al
    Atlas for reporting PET myocardial perfusion imaging and myocardial blood flow in clinical practice: an information statement from the American Society of Nuclear Cardiology.
    J Nucl Cardiol. 2023 Oct 27. doi: 10.1007/s12350-023-03378.
    >> Share

  260. JOHNSRUD DO, Port SC
    In 2023 invasive coronary angiography is preferred to PET myocardial perfusion imaging for the initial work-up of a symptomatic patient with a high coronary artery calcium score.
    J Nucl Cardiol. 2023 Oct 16. doi: 10.1007/s12350-023-03385.
    >> Share

  261. KRAKAUER M, Ismail A, Talleruphuus U, Henriksen AC, et al
    (82)Rb and [(15)O]H(2)O myocardial perfusion PET imaging: a prospective head to head comparison.
    J Nucl Cardiol. 2023 Oct 3. doi: 10.1007/s12350-023-03372.
    >> Share

  262. LOHARKAR S, Sonavane SN, Shah H, Basu S, et al
    What is this image? 2023 Image 3 results: Cardiac tuberculosis presenting as cardiac mass: role of (18)F-FDG PET/CT in monitoring response to treatment.
    J Nucl Cardiol. 2023 Oct 2. doi: 10.1007/s12350-023-03381.
    >> Share

  263. MAIR BA, Zelt JGE, Nekesa K, Saint-Georges Z, et al
    Pharmacological and metabolic parameters of [(18)F]flubrobenguane in clinical imaging populations.
    J Nucl Cardiol. 2023;30:2089-2095.
    >> Share

  264. BULLOCK-PALMER RP
    Utility of myocardial blood flow assessment with dynamic CZT single photon emission computed tomography in patients with myocardial bridging: Is this 'wishful thinking' in this dynamic situation?
    J Nucl Cardiol. 2023;30:2068-2072.
    >> Share

  265. IBRAHIM J, Soman P
    The past, present, and future of attenuation correction for myocardial perfusion imaging.
    J Nucl Cardiol. 2023;30:1794-1796.
    >> Share

  266. TOTTLEBEN J, Torres A, Doukky R
    Impact of change of ischemic burden on the outcomes of ESRD patients awaiting kidney transplantation.
    J Nucl Cardiol. 2023;30:1897-1903.
    >> Share

  267. DAKIK HA, Ghazzal Z, Haidar M
    Screening asymptomatic patients post PCI with myocardial perfusion imaging.
    J Nucl Cardiol. 2023;30:2248-2251.
    >> Share

  268. NAYFEH M, Ahmed AI, Al-Mallah MH
    Unveiling the hidden link: deciphering the interplay between plaque characteristics and nuclear myocardial perfusion imaging.
    J Nucl Cardiol. 2023;30:1851-1855.
    >> Share

  269. HEDEER F, Akil S, Oddstig J, Hindorf C, et al
    Diagnostic accuracy for CZT gamma camera compared to conventional gamma camera technique with myocardial perfusion single-photon emission computed tomography: Assessment of myocardial infarction and function.
    J Nucl Cardiol. 2023;30:1935-1946.
    >> Share

  270. AL TAHA Z, Alibazoglu D, Sabbour H, Romany I, et al
    Attacking the Achilles heel of cardiac amyloid nuclear scintigraphy: How to reduce equivocal and false positive studies.
    J Nucl Cardiol. 2023;30:1922-1934.
    >> Share

  271. WANG Y, Yu W, Yang X, Zhang F, et al
    Left ventricular systolic dyssynchrony: a novel imaging marker for early assessment of myocardial damage in Chinese type 2 diabetes mellitus patients with normal left ventricular ejection fraction and normal myocardial perfusion.
    J Nucl Cardiol. 2023;30:1797-1809.
    >> Share

  272. VALZANIA C, Paccagnella A, Spadotto A, Ruotolo I, et al
    Early detection of cancer therapy cardiotoxicity by radionuclide angiography: An update.
    J Nucl Cardiol. 2023;30:2104-2111.
    >> Share

  273. ANDERSSON Y, Fernandez G, Mars P, Lindow T, et al
    Significant myocardial perfusion defect during stress visible in prone but not in supine imaging.
    J Nucl Cardiol. 2023;30:2209-2212.
    >> Share

  274. DORAN JA, Sajjad W, Schneider MD, Gupta R, et al
    Retraction Note: Aminophylline and caffeine for reversal of adverse symptoms associated with regadenoson SPECT MPI.
    J Nucl Cardiol. 2023;30:2254.
    >> Share

  275. NIELSEN MO, Schledermann H, Jensen LT
    Primary breast cancer diagnosed by 82-Rubidium myocardial perfusion PET-scan.
    J Nucl Cardiol. 2023;30:2252-2253.
    >> Share

  276. DAKIK HA, Ghazzal Z, Haidar M
    Screening asymptomatic patients post PCI with myocardial perfusion imaging.
    J Nucl Cardiol. 2023;30:2248-2251.
    >> Share

  277. CHEN LQ, Nichols KJ, Van Tosh A
    Exercise ECG must be considered in conjunction with conventional SPECT.
    J Nucl Cardiol. 2023;30:2245-2247.
    >> Share

  278. SUTHERLAND N, Sivaratnam D, Pearson M, Better N, et al
    Use of SPECT imaging to confirm ATTR cardiac amyloid in a Tc99m pyrophosphate study artefactually compromised by a recent V/Q scan.
    J Nucl Cardiol. 2023;30:2242-2244.
    >> Share

  279. AIKAWA T, Manabe O, Ibe T, Oyama-Manabe N, et al
    Serial assessment of cardiac involvement in sarcoidosis by delayed (18)F-fluorodeoxyglucose PET/CT.
    J Nucl Cardiol. 2023;30:2225-2228.
    >> Share

  280. ZMAILI M, Jaber W
    First experience of LVEF assessment with cardiac amyloid SPECT scan.
    J Nucl Cardiol. 2023;30:2222-2224.
    >> Share

  281. TAKAHASHI K, Morioka H, Sasaki D, Yamamura N, et al
    Two autopsy cases of wild-type transthyretin cardiac amyloidosis who died 10 days after technetium-99m-pyrophosphate scintigraphy.
    J Nucl Cardiol. 2023;30:2215-2221.
    >> Share

  282. JALEEL J, Patel C, Khangembam B, Kumar S, et al
    Utility of 68Ga-DOTANOC PET/CT in therapeutic monitoring of cardiac sarcoidosis.
    J Nucl Cardiol. 2023;30:2213-2214.
    >> Share

  283. TAKAHASHI K, Sasaki D, Uemura S, Okura T, et al
    (99m)Tc-PYP SPECT/CT as part of the diagnostic workup of left ventricular apical aneurysm in a patient with hypertrophic cardiomyopathy.
    J Nucl Cardiol. 2023;30:2198-2203.
    >> Share

  284. QAMAR I, Grewal S, Fahed AC, Weiner R, et al
    PET myocardial perfusion imaging of regadenoson-induced coronary vasospasm.
    J Nucl Cardiol. 2023;30:2187-2190.
    >> Share

  285. DILSIZIAN V, Bacharach SL, Beanlands RS, Bergmann SR, et al
    Correction to: ASNC imaging guidelines/SNMMI procedure standard for positron emission tomography (PET) nuclear cardiology procedures.
    J Nucl Cardiol. 2023;30:2186.
    >> Share

  286. HORGAN S, Sanghani R, Miller S, Al-Mallah M, et al
    ASNC model coverage policy: 2023 cardiac positron emission tomography.
    J Nucl Cardiol. 2023;30:2114-2185.
    >> Share

  287. VALZANIA C, Paccagnella A, Spadotto A, Ruotolo I, et al
    Early detection of cancer therapy cardiotoxicity by radionuclide angiography: An update.
    J Nucl Cardiol. 2023;30:2104-2111.
    >> Share

  288. BUCY L, Erpelding ML, Boursier C, Lefevre B, et al
    Real world experience of therapeutic monitoring of medically treated prosthetic valve infective endocarditis by (18)F-FDG-PET/CT.
    J Nucl Cardiol. 2023;30:2096-2103.
    >> Share

  289. MAIR BA, Zelt JGE, Nekesa K, Saint-Georges Z, et al
    Pharmacological and metabolic parameters of [(18)F]flubrobenguane in clinical imaging populations.
    J Nucl Cardiol. 2023;30:2089-2095.
    >> Share

  290. BENTSEN S, Jensen JK, Christensen E, Petersen LR, et al
    [(68)Ga]Ga-NODAGA-E[(cRGDyK)](2) angiogenesis PET following myocardial infarction in an experimental rat model predicts cardiac functional parameters and development of heart failure.
    J Nucl Cardiol. 2023;30:2073-2084.
    >> Share

  291. BULLOCK-PALMER RP
    Utility of myocardial blood flow assessment with dynamic CZT single photon emission computed tomography in patients with myocardial bridging: Is this 'wishful thinking' in this dynamic situation?
    J Nucl Cardiol. 2023;30:2068-2072.
    >> Share

  292. XU R, Yang H, Zhang J, Chen S, et al
    Dynamic perfusion SPECT for functional evaluation in symptomatic patients with myocardial bridging.
    J Nucl Cardiol. 2023;30:2058-2067.
    >> Share

  293. PETRETTA M, Panico M, Mainolfi CG, Cuocolo A, et al
    Including myocardial flow reserve by PET in prediction models: Ready to fly?
    J Nucl Cardiol. 2023;30:2054-2057.
    >> Share

  294. MIURA S, Okizaki A, Kumamaru H, Manabe O, et al
    Interaction of impaired myocardial flow reserve and extent of myocardial ischemia assessed using (13)N-ammonia positron emission tomography imaging on adverse cardiovascular outcomes.
    J Nucl Cardiol. 2023;30:2043-2053.
    >> Share

  295. HULTEN E, Keating FK
    Diagnosis of diffuse ischemia with SPECT relative perfusion imaging: How to eat soup with a fork?
    J Nucl Cardiol. 2023;30:2039-2042.
    >> Share

  296. KUPUSOVIC J, Kessler L, Bruns F, Bohnen JE, et al
    Visualization of fibroblast activation using (68)Ga-FAPI PET/CT after pulmonary vein isolation with pulsed field compared with cryoballoon ablation.
    J Nucl Cardiol. 2023;30:2018-2028.
    >> Share

  297. MALLET F, Poitrasson-Riviere A, Mariano-Goulart D, Agostini D, et al
    Measuring myocardial blood flow using dynamic myocardial perfusion SPECT: artifacts and pitfalls.
    J Nucl Cardiol. 2023;30:2006-2017.
    >> Share

  298. DAI N, Zhang B, Gong Z, Dong Z, et al
    Quantitative flow ratio derived pullback pressure gradient and CZT-SPECT measured longitudinal flow gradient for hemodynamically significant coronary artery disease.
    J Nucl Cardiol. 2023;30:1992-2002.
    >> Share

  299. WANG A, Mahmood U, Tang X, Jain D, et al
    A case of disappearing amyloid on technetium pyrophosphate scan.
    J Nucl Cardiol. 2023;30:1986-1991.
    >> Share

  300. TANG X, Dai N, Zhang B, Cai H, et al
    Comparison of 2D-QCA, 3D-QCA and coronary angiography derived FFR in predicting myocardial ischemia assessed by CZT-SPECT MPI.
    J Nucl Cardiol. 2023;30:1973-1982.
    >> Share

  301. NAKAJIMA K, Shibutani T
    Are nuclear medicine images quantified in 2D and 3D equally functional?
    J Nucl Cardiol. 2023;30:1968-1972.
    >> Share

  302. IMOTO A, Tateishi E, Murakawa K, Ohta Y, et al
    Lung-to-heart ratio analysis using virtual planar images obtained from myocardial perfusion SPECT data: A phantom and clinical studies.
    J Nucl Cardiol. 2023;30:1959-1967.
    >> Share

  303. FUKUSHIMA K, Endo K, Yamakuni R, Kiko T, et al
    Simultaneous assessment of left ventricular mechanical dyssynchrony using integrated (13)N-ammonia PETMR system: direct comparison of PET phase analysis and MR feature tracking.
    J Nucl Cardiol. 2023;30:1947-1958.
    >> Share

  304. HEDEER F, Akil S, Oddstig J, Hindorf C, et al
    Diagnostic accuracy for CZT gamma camera compared to conventional gamma camera technique with myocardial perfusion single-photon emission computed tomography: Assessment of myocardial infarction and function.
    J Nucl Cardiol. 2023;30:1935-1946.
    >> Share

  305. AL TAHA Z, Alibazoglu D, Sabbour H, Romany I, et al
    Attacking the Achilles heel of cardiac amyloid nuclear scintigraphy: How to reduce equivocal and false positive studies.
    J Nucl Cardiol. 2023;30:1922-1934.
    >> Share

  306. QUTBI M
    Adjustment of acquisition arc in cardiac malposition during myocardial perfusion SPECT imaging: computer simulation based on deterministic modeling.
    J Nucl Cardiol. 2023;30:1910-1921.
    >> Share

  307. TOTTLEBEN J, Torres A, Doukky R
    Impact of change of ischemic burden on the outcomes of ESRD patients awaiting kidney transplantation.
    J Nucl Cardiol. 2023;30:1897-1903.
    >> Share

  308. KOENDERS SS, van Dalen JA, Jager PL, Mouden M, et al
    Patient-tailored risk assessment of obstructive coronary artery disease using Rubidium-82 PET-based myocardial flow quantification with visual interpretation.
    J Nucl Cardiol. 2023;30:1890-1896.
    >> Share

  309. HANAOKA K, Watanabe S, Morimoto-Ishikawa D, Kaida H, et al
    Impact of respiratory gating and ECG gating on (18)F-FDG PET/CT for cardiac sarcoidosis.
    J Nucl Cardiol. 2023;30:1879-1885.
    >> Share

  310. CHEN X, Liu C
    Deep-learning-based methods of attenuation correction for SPECT and PET.
    J Nucl Cardiol. 2023;30:1859-1878.
    >> Share

  311. NAYFEH M, Ahmed AI, Al-Mallah MH
    Unveiling the hidden link: deciphering the interplay between plaque characteristics and nuclear myocardial perfusion imaging.
    J Nucl Cardiol. 2023;30:1851-1855.
    >> Share

  312. HIJAZI W, Miller RJH
    Deep learning to automate SPECT MPI myocardial reorientation.
    J Nucl Cardiol. 2023;30:1836-1837.
    >> Share

  313. ZHU F, Wang G, Zhao C, Malhotra S, et al
    Automatic reorientation by deep learning to generate short-axis SPECT myocardial perfusion images.
    J Nucl Cardiol. 2023;30:1825-1835.
    >> Share

  314. GATTERER C, Wollenweber T, Pichler V, Vraka C, et al
    Detection of sympathetic denervation defects in Fabry disease by hybrid [(11)C]meta-hydroxyephedrine positron emission tomography and cardiac magnetic resonance.
    J Nucl Cardiol. 2023;30:1810-1821.
    >> Share

  315. WANG Y, Yu W, Yang X, Zhang F, et al
    Left ventricular systolic dyssynchrony: a novel imaging marker for early assessment of myocardial damage in Chinese type 2 diabetes mellitus patients with normal left ventricular ejection fraction and normal myocardial perfusion.
    J Nucl Cardiol. 2023;30:1797-1809.
    >> Share

  316. IBRAHIM J, Soman P
    The past, present, and future of attenuation correction for myocardial perfusion imaging.
    J Nucl Cardiol. 2023;30:1794-1796.
    >> Share

  317. CHOPRA S, Singh SS, Sood A, Parmar M, et al
    Comparison of positional artifacts in myocardial perfusion imaging in supine and semi-reclining position using dedicated D-SPECT cardiac camera: validation using CT based attenuation correction.
    J Nucl Cardiol. 2023;30:1782-1793.
    >> Share

  318. SALEH JK, Barkmeier D, Frey KA, Davenport MS, et al
    Diagnostic yield of whole-body (18)F-FDG PET/CT in patients with suspected cardiac sarcoidosis.
    J Nucl Cardiol. 2023;30:1773-1781.
    >> Share

  319. KUPUSOVIC J, Weber M, Bruns F, Kessler L, et al
    PET/CT-identified atrial hypermetabolism is an index of atrial inflammation in patients with atrial fibrillation.
    J Nucl Cardiol. 2023;30:1761-1772.
    >> Share

  320. BERMAN DS
    Making fair comparisons: The potency and necessity of combining myocardial perfusion imaging and CAC scanning.
    J Nucl Cardiol. 2023;30:1751-1755.
    >> Share

  321. BERMAN DS
    Making fair comparisons: The potency and necessity of combining myocardial perfusion imaging and CAC scanning.
    J Nucl Cardiol. 2023;30:1751-1755.
    >> Share

    September 2023
  322. JAHANDIDEH A, Virta J, Li XG, Liljenback H, et al
    Vascular adhesion protein-1-targeted PET imaging in autoimmune myocarditis.
    J Nucl Cardiol. 2023 Sep 27. doi: 10.1007/s12350-023-03371.
    >> Share

  323. ADHADUK M, Paudel B, Liu K, Ashwath M, et al
    Comparison of cardiac magnetic resonance imaging and fluorodeoxyglucose positron emission tomography in the assessment of myocardial viability: meta-analysis and systematic review.
    J Nucl Cardiol. 2023 Sep 27. doi: 10.1007/s12350-023-03377.
    >> Share

  324. LIMA BB, Benz DC
    Casting aside the creep: harnessing cardiorespiratory dynamics to optimize myocardial flow assessment in cardiac PET.
    J Nucl Cardiol. 2023 Sep 20. doi: 10.1007/s12350-023-03376.
    >> Share

  325. HORGAN S, Sanghani R, Miller S, Al-Mallah M, et al
    ASNC model coverage policy: 2023 cardiac positron emission tomography.
    J Nucl Cardiol. 2023 Sep 5. doi: 10.1007/s12350-023-03355.
    >> Share

    August 2023
  326. MIYATAKE M, Norikane T, Imajo M, Takami Y, et al
    LV functional evaluation on (11)C-PiB PET/CT in cardiac amyloidosis.
    J Nucl Cardiol. 2023;30:1693-1696.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016